menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Anticoagulant Treatments for Special Patient Populations

close
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Several factors impact our ability to safely and effectively prescribe warfarin and other anticoagulants. These issues include genetics, weight, renal impairment, and the potential for heparin-induced thrombocytopenia. How can we continue to improve our recognition of these factors that affect our patients' capacity to metabolize anticoagulants? Dr. Kate Phillips, clinical specialist in cardiology and anticoagulation at the Boston Medical Center, speaks with host Dr. Charles Turck about the challenges of anticoagulant therapy dosing, as well as the variation in response to therapy, based on ethnicity and other factors.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Several factors impact our ability to safely and effectively prescribe warfarin and other anticoagulants. These issues include genetics, weight, renal impairment, and the potential for heparin-induced thrombocytopenia. How can we continue to improve our recognition of these factors that affect our patients' capacity to metabolize anticoagulants? Dr. Kate Phillips, clinical specialist in cardiology and anticoagulation at the Boston Medical Center, speaks with host Dr. Charles Turck about the challenges of anticoagulant therapy dosing, as well as the variation in response to therapy, based on ethnicity and other factors.

Facebook Comments

Schedule19 Oct 2021